Selection and Characterization of a DNA Aptamer Recognizing High Mobility Group Box 1 Protein (HMGB1) and Enhancing Its Pro-inflammatory Activity
Iranian Journal of Pharmaceutical Research · 11.09.2024 · 23 (1)
DOI: 10.5812/ijpr-147246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 11.09.2024. Verfasst von Hanchao Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, The People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Mobilisation
Abstract (Originalsprache)
Background
High mobility group box 1 (HMGB1) plays an essential role in various pathological conditions, including inflammation, fibrosis, autoimmune diseases, and carcinogenesis. The quantification of HMGB1 in body fluids holds promise for clinical applications.
Objectives
This study aimed to isolate high-affinity single-stranded DNA (ssDNA) aptamers that target HMGB1.
Methods
In this study, ssDNA aptamers were selected using Systematic Evolution of Ligands by Exponential Enrichment (SELEX). The affinity and specificity of the aptamers were evaluated through South-Western blot analysis, enzyme-linked aptamer sorbent assay (ELASA), and aptamer-based histochemistry staining. The impact of the aptamers on the biological activity of HMGB1 was tested in the human acute monocytic leukemia cell line, THP-1.
Results
An aptamer (H-ap25, dissociation constant = 8.20 ± 0.53 nmol/L) with high affinity for the HMGB1 B box was generated. Further experiments verified that H-ap25 can be used to detect HMGB1 in South-Western blot analysis, ELASA, and aptamer-based histochemistry staining. Moreover, H-ap25 significantly augmented HMGB1-induced expression of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, Toll-like receptor 9 (TLR9), and activation of NF-κB in THP-1 cells.
Conclusions
Our results demonstrated that H-ap25 can be used both as an enhancer of HMGB1 and as a probe in research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, The People's Republic of China.
- Department of Rheumatology, Weihai Central Hospital, Weihai, Shandong Province, The People's Republic of China.
- Department of Gastroenterology, Affiliated Haimen Hospital of Xinglin College, Nantong University, Nantong, Jiangsu Province, The People's Republic of China.
- Department of Anatomy, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi Province, The People's Republic of China.
ORCID-Profile: Yongwei Huo
Zitieren
APA
Li, H., Sun, W., Huang, Y., Li, Q., Tian, H., Hao, Z., & Huo, Y. (2024). Selection and Characterization of a DNA Aptamer Recognizing High Mobility Group Box 1 Protein (HMGB1) and Enhancing Its Pro-inflammatory Activity. Iranian Journal of Pharmaceutical Research, 23(1). https://doi.org/10.5812/ijpr-147246
Vancouver
Li H, Sun W, Huang Y, Li Q, Tian H, Hao Z, et al. Selection and Characterization of a DNA Aptamer Recognizing High Mobility Group Box 1 Protein (HMGB1) and Enhancing Its Pro-inflammatory Activity. Iranian Journal of Pharmaceutical Research. 2024;23(1). doi:10.5812/ijpr-147246
BibTeX
@article{Li2024,
author = {Li, Hanchao and Sun, Wengang and Huang, Yanhua and Li, Qian and Tian, Hong and Hao, Zhiming and Huo, Yongwei},
title = {Selection and Characterization of a DNA Aptamer Recognizing High Mobility Group Box 1 Protein (HMGB1) and Enhancing Its Pro-inflammatory Activity},
journal = {Iranian Journal of Pharmaceutical Research},
year = {2024},
volume = {23},
number = {1},
doi = {10.5812/ijpr-147246}
}
EUVIMED